P. Quach

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy

W. Rubas, J. Zalevsky, Yinyan Tang, 2021, Journal for ImmunoTherapy of Cancer.

Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma

E. Kleinerman, J. Zalevsky, S. Kivimäe, 2020, International journal of cancer.

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

W. Rubas, D. Gauvin, J. Zalevsky, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Abstract 1603: NKTR-255 engages the IL-15 pathway driving CD8 T cell survival and CD8 memory T cell proliferation

C. Fanton, J. Zalevsky, M. Addepalli, 2017 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

W. Rubas, D. Gauvin, J. Zalevsky, 2017, The Journal of Pharmacology and Experimental Therapeutics.